Literature DB >> 19875966

Bridging clinical investigators and statisticians: writing the statistical methodology for a research proposal.

Beverley Adams-Huet1, Chul Ahn.   

Abstract

Clinical investigators often find the thought of writing the statistical analysis plan daunting. Early collaboration between the clinical investigator and statistician can improve the study design and validity of the results by developing the statistical methodology that specifically addresses the research hypothesis. With the clinical investigator, a statistician often writes the statistical methods section that includes sample size and power analyses, randomization and blinding procedures, interim analysis, and data monitoring plans, in addition to the statistical analysis plan. To make this process less mysterious, we describe how the statistical methods section is developed in collaboration with a statistician.

Entities:  

Mesh:

Year:  2009        PMID: 19875966      PMCID: PMC4415704          DOI: 10.2310/JIM.0b013e3181c2996c

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  11 in total

Review 1.  Statistics notes: blinding in clinical trials and other studies.

Authors:  S J Day; D G Altman
Journal:  BMJ       Date:  2000 Aug 19-26

2.  How statistical expertise is used in medical research.

Authors:  Douglas G Altman; Steven N Goodman; Sara Schroter
Journal:  JAMA       Date:  2002-06-05       Impact factor: 56.272

3.  Design and analysis of pilot studies: recommendations for good practice.

Authors:  Gillian A Lancaster; Susanna Dodd; Paula R Williamson
Journal:  J Eval Clin Pract       Date:  2004-05       Impact factor: 2.431

4.  Effect of dropouts on sample size estimates for test on trends across repeated measurements.

Authors:  Chul Ahn; Sin-Ho Jung
Journal:  J Biopharm Stat       Date:  2005       Impact factor: 1.051

5.  Statistical considerations in the intent-to-treat principle.

Authors:  J M Lachin
Journal:  Control Clin Trials       Date:  2000-06

6.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

7.  Interim analysis: the alpha spending function approach.

Authors:  D L DeMets; K K Lan
Journal:  Stat Med       Date:  1994 Jul 15-30       Impact factor: 2.373

8.  A multiple testing procedure for clinical trials.

Authors:  P C O'Brien; T R Fleming
Journal:  Biometrics       Date:  1979-09       Impact factor: 2.571

9.  Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.

Authors:  R D Toto; B Adams-Huet; A Z Fenves; H C Mitchell; W Mulcahy; R D Smith
Journal:  Am J Kidney Dis       Date:  1996-12       Impact factor: 8.860

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  9 in total

1.  Ensconcing a biostatistics clinic in tertiary care research institute of India: A descriptive study.

Authors:  Kishore Kamal; Meenakshi Sharma; Mahajan Rahul; Kapoor Rakesh; Vipin Koushal
Journal:  J Family Med Prim Care       Date:  2022-05-14

2.  Biostatistics teaching to the undergraduate medical students through research-oriented medical education posting program in a Teaching Medical Institute in Coastal Area of Pondicherry: An experience of a biostatistician.

Authors:  Senthilvel Vasudevan
Journal:  J Pharm Bioallied Sci       Date:  2016 Jan-Mar

3.  Statistical Basic Steps to Be Considered on Planning a Research.

Authors:  Cristina Pires Camargo; Rolf Gemperli
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-04-12

Review 4.  Factors influencing the statistical planning, design, conduct, analysis and reporting of trials in health care: A systematic review.

Authors:  Marina Zaki; Lydia O'Sullivan; Declan Devane; Ricardo Segurado; Eilish McAuliffe
Journal:  Contemp Clin Trials Commun       Date:  2022-01-29

5.  Statistical advising: Professional development opportunities for the biostatistician.

Authors:  Marissa LeBlanc; Corina S Rueegg; Nural Bekiroğlu; Tonya M Esterhuizen; Morten W Fagerland; Ragnhild S Falk; Kathrine F Frøslie; Erika Graf; Georg Heinze; Ulrike Held; René Holst; Theis Lange; Madhu Mazumdar; Ida H Myrberg; Martin Posch; Jamie C Sergeant; Werner Vach; Eric A Vance; Harald Weedon-Fekjaer; Manuela Zucknick
Journal:  Stat Med       Date:  2022-02-28       Impact factor: 2.497

6.  Patient enrollment and logistical problems top the list of difficulties in clinical research: a cross-sectional survey.

Authors:  Stéphane Cullati; Delphine S Courvoisier; Angèle Gayet-Ageron; Guy Haller; Olivier Irion; Thomas Agoritsas; Sandrine Rudaz; Thomas V Perneger
Journal:  BMC Med Res Methodol       Date:  2016-05-04       Impact factor: 4.615

7.  A protocol for a systematic review investigating the factors influencing the statistical planning, design, conduct, analysis and reporting of trials.

Authors:  Marina Zaki; Marie Galligan; Lydia O'Sullivan; Declan Devane; Eilish McAuliffe
Journal:  HRB Open Res       Date:  2020-09-24

8.  Coronary risk reduction intervention for siblings and offspring of patients with premature coronary heart disease: the CRISO study protocol for a randomised controlled pilot study.

Authors:  Justin Lee Mifsud; John Stephenson; Felicity Astin; Joseph Galea
Journal:  Pilot Feasibility Stud       Date:  2021-08-09

9.  Methodology over metrics: current scientific standards are a disservice to patients and society.

Authors:  Ben Van Calster; Laure Wynants; Richard D Riley; Maarten van Smeden; Gary S Collins
Journal:  J Clin Epidemiol       Date:  2021-05-30       Impact factor: 6.437

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.